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and Intensive Care Medicine and 
institutional	and/or	departmental	sources.
The	Scandinavian	Society	of	Anaesthesiology	and	Intensive	Care	Medicine	Clinical	
Practice	 Committee	 endorses	 the	 recent	 DASAIM/DSIT guideline for prevention of 









rhabdomyolysis	 and	 is	most	often	 treated	with	 fluid	 resuscitation,	
along	with	several	supportive	strategies	including	diuretics,	urinary	
alkalinization,	 antioxidants	 and	 renal	 replacement	 therapy.1-4 Best 
practice	recommendations	have	been	difficult	 to	 formulate	due	to	
incomplete	 understanding	 of	 the	 pathogenesis	 behind	 rhabdomy-
olysis	induced	AKI,	lack	of	consensus	definitions	and	lack	of	human	
studies.	 In	 2019,	 the	 Danish	 Society	 of	 Intensive	 Care	 Medicine	
(DSIT)	and	the	Danish	Society	of	Anesthesiology	and	Intensive	Care	
Medicine	 (DASAIM)	 summarized	 the	 available	 evidence	 and	 pro-





assess	the	DASAIM/DSIT guideline on the prevention of rhabdomyolysis 
induced AKI	for	possible	endorsement.	The	Appraisal	of	Guidelines	
for	REsearch	and	Evaluation	(AGREE)	II	tool,6 was used. Details on 
the	endorsement	process	is	available	elsewhere.7
3  | RESULTS
3.1 | Quality appraisal (AGREE II)
Five	 out	 of	 six	 SSAI	 CPC	members	 completed	 the	 appraisal.	 One	
member	co‐authored	the	guideline	and	was	excluded	from	the	eval-
uation,	as	per	the	SSAI	endorsement	process.6




The	 breakdown	 of	 the	 individual	 appraisers	 (de‐identified)	 is	
available	in	the	supplementary	material.
4  | DISCUSSION
There	was	 acceptable	 agreement	 between	 the	 SSAI	CPC	 apprais-
ers	 in	most	 domains.	However,	 there	were	 notable	 limitations	 re-
lated	to	the	applicability	of	the	guidelines	due	to	lack	of	high‐quality	
evidence,	including	data	from	randomized	clinical	trials	in	the	target	




caregivers and regulatory bodies.
5  | CONCLUSION
The	SSAI	CPC	endorses	the	DASAIM/DSIT	Clinical	Practice	Guideline	
on	Prevention	of	 rhabdomyolysis‐induced	AKI,	 acknowledging	 the	
poor	quality	of	evidence	underpinning	its	recommendations.
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SUPPORTING INFORMATION
Additional	 supporting	 information	 may	 be	 found	 online	 in	 the	
Supporting	Information	section	at	the	end	of	the	article.	
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